

LONDON (Alliance News) - Motif Bio PLC on Tuesday said it has netted GBP36,514 following the exercise of share warrants.The pharmaceutical company sai...


LONDON (Alliance News) - Amphion Innovations PLC on Tuesday said it has restructured its loan payments and agreed a further USD1.1 million draw-down.A...


LONDON (Alliance News) - Amphion Innovations PLC said Tuesday it sold 3 million shares in Motif Bio PLC to institutional investors at 33.5 pence each,...


LONDON (Alliance News) - Motif Bio PLC said Wednesday it has been given a Notice of Allowance from the US Patent & Trademark Office for use of its ant...


LONDON (Alliance News) - Clinical-stage biopharmaceutical company Motif Bio PLC said Tuesday that Director Robert Bertoldi will resign from the board ...


LONDON (Alliance News) - Amphion Innovations PLC said on Wednesday it sold 8.9 million shares in partner company Motif Bio PLC to partially repay a lo...


LONDON (Alliance News) - Biopharmaceutical firm Motif Bio PLC said it has successfully raised GBP10 million via an accelerated bookbuild exercise on T...


LONDON (Alliance News) - Motif Bio PLC said it plans to raise GBP10 million via an accelerated bookbuild exercise, which will launch on Thursday.The f...